Clinical Outcome Of Single Agent Volasertib (Bi 6727) As Second-Line Treatment Of Patients (Pts) With Advanced Or Metastatic Urothelial Cancer (Uc).

JOURNAL OF CLINICAL ONCOLOGY(2011)

引用 10|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要